Page last updated: 2024-08-23

plicamycin and Body Weight

plicamycin has been researched along with Body Weight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jia, Y; Jiang, Z; Li, R; Ni, Y; Yang, X; Zhao, R; Zou, H	1
Chang, DZ; Gao, Y; Huang, S; Jia, Z; Le, X; Li, Q; Wang, L; Wei, D; Xie, K; Yao, JC; Zhang, J	1

Other Studies

2 other study(ies) available for plicamycin and Body Weight

Article	Year
p53 cooperates with Sp1 to regulate breed-dependent expression of glucocorticoid receptor in the liver of preweaning piglets. PloS one, 2013, Volume: 8, Issue:8 Topics: Acetylation; Animals; Blotting, Western; Body Weight; Doxorubicin; Gene Expression; Hep G2 Cells; Histones; Humans; Hydrocortisone; Liver; Plicamycin; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Species Specificity; Swine; Tumor Suppressor Protein p53; Weaning	2013
Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer research, 2010, Feb-01, Volume: 70, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Body Weight; Cell Line, Tumor; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; ortho-Aminobenzoates; Pancreatic Neoplasms; Plicamycin; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2010

Article

Year

p53 cooperates with Sp1 to regulate breed-dependent expression of glucocorticoid receptor in the liver of preweaning piglets.

PloS one, 2013, Volume: 8, Issue:8

Topics: Acetylation; Animals; Blotting, Western; Body Weight; Doxorubicin; Gene Expression; Hep G2 Cells; Histones; Humans; Hydrocortisone; Liver; Plicamycin; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Species Specificity; Swine; Tumor Suppressor Protein p53; Weaning

2013

Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.

Cancer research, 2010, Feb-01, Volume: 70, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Body Weight; Cell Line, Tumor; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; ortho-Aminobenzoates; Pancreatic Neoplasms; Plicamycin; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2010